Home > Events > DIA Japan 2026

DIA Japan 2026

  • Chisako Mizutani

    Country Manager, Japan

The 2026 meeting runs under the theme “Crossing Boundaries, Shaping a Future Beyond Imagination with Innovation”, with sessions spanning regulatory reform, clinical development, patient-centric approaches, post-marketing surveillance and the growing role of digital tools and AI. For anyone planning a trial, a submission or a launch in Japan, it is three days close to the people who shape how medicines reach patients here. Akesa will be there throughout.

Who should attend

DIA Japan draws the people who move a therapy from global plan to Japanese reality. It is worth a conversation with us if you are:

  • A regulatory affairs team working on Japanese submissions and global-to-Japan strategy
  • A clinical development or clinical operations team planning or running trials in Japan
  • A clinical supply or sourcing team responsible for comparators and standard of care
  • A sponsor, biotech or CRO bridging global standards with Japanese requirements

Meet Akesa in Tokyo

Japan is one of Akesa’s core markets, and DIA Japan is where its regulatory, clinical and access communities gather. Akesa is the operational partner behind clinical trial supply and medicine access across the Asia-Pacific region. We source comparators, combination therapies and standard of care for clinical trials. If you are bringing a trial or a therapy into Japan, our Country Manager for Japan, Chisako Mizutani, will be there and glad to talk it through.

Event links

Get in touch

If a Japan submission, trial or launch is on your roadmap, get in touch and we will set time aside in Tokyo.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.